Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01534650 · ClinicalTrials.gov registry record
Movement Disorder Quantification Algorithm Development
A clinical trial, sponsored by Great Lakes NeuroTechnologies.
- Completed
- Registry status
- 17
- Enrollment target
NCT01534650 is a clinical trial that has completed, run by Great Lakes NeuroTechnologies. The registered enrollment target is 17 participants.
The verdict
NCT01534650 has completed, sponsored by Great Lakes NeuroTechnologies.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to collect kinematic motion data from subjects with movement disorders such as Parkinson's disease (PD) and essential tremor (ET) to develop and validate algorithms for quantifying motor symptoms such as tremor, bradykinesia (slowed movements), dyskinesias (sudden, involuntary movements), gait, and balance during standardized tasks and/or activities of daily living.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2012-02 |
| Est. Completion | 2016-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01534650
The ClinicalTrials.gov registry entry for NCT01534650 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Great Lakes NeuroTechnologies, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01534650 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01534650 about?
NCT01534650 is a clinical study titled "Movement Disorder Quantification Algorithm Development". The purpose of this study is to collect kinematic motion data from subjects with movement disorders such as Parkinson's disease (PD) and essential tremor (ET) to develop and validate algorithms for quantifying motor symptoms such as tremor, bradykinesia (slowed movements), dyskinesias (sudden, invol...
What is the current status of trial NCT01534650?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2012-02. Estimated completion is 2016-01.
Who is sponsoring clinical trial NCT01534650?
This trial is sponsored by Great Lakes NeuroTechnologies, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.